Quetiapine modified-release versus immediate-release in early psychosis

被引：0
|
作者：
Kelbrick, Marlene [1 ]
机构：
[1] Northamptonshire Healthcare NHS Fdn Trust, Early Intervent Psychosis, Kettering, England
来源：
PROGRESS IN NEUROLOGY AND PSYCHIATRY | 2019年 / 23卷 / 04期
关键词：
REPORTED SEDATION PROFILE; 1ST-EPISODE PSYCHOSIS; EXTENDED-RELEASE; DOUBLE-BLIND; ANTIPSYCHOTIC MEDICATION; BIPOLAR DEPRESSION; SCHIZOPHRENIA; MANAGEMENT; EFFICACY; NONADHERENCE;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Antipsychotic treatment choice in first-episode psychosis is multifaceted with a need to focus on all aspects of recovery. There are clear differences between quetiapine immediaterelease (IR) and modified-release (MR) that may have clinical significance in this patient group.
引用
收藏
页码：29 / 31
页数：3
相关论文
共 50 条
  • [31] Human abuse potential of immediate-release/extended-release versus immediate-release hydrocodone bitartrate/acetaminophen: a randomized controlled trial in recreational users of prescription opioids
    Devarakonda, Krishna
    Kostenbader, Kenneth
    Zheng, Yanping
    Montgomery, Jeannie B.
    Barrett, Thomas
    Young, Jim L.
    Webster, Lynn R.
    POSTGRADUATE MEDICINE, 2015, 127 (01) : 13 - 21
  • [32] Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release
    Figueroa, Carlos
    Brecher, Martin
    Hamer-Maansson, Jennifer E.
    Winter, Helen
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2009, 33 (02): : 199 - 204
  • [33] A 26-week feasibility study comparing the efficacy and safety of modified-release prednisone with immediate-release prednisolone in newly diagnosed cases of giant cell arteritis
    Raine, Charles
    Stapleton, Philip P.
    Merinopoulos, Dimos
    Maw, Win Win
    Achilleos, Katerina
    Gayford, Dawn
    Mapplebeck, Sarah
    Mackerness, Craig
    Schofield, Paul
    Dasgupta, Bhaskar
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (01) : 285 - 291
  • [34] RELATIVE BIOAVAILABILITY OF 2 SUSTAINED-RELEASE THEOPHYLLINE FORMULATIONS VERSUS AN IMMEDIATE-RELEASE PREPARATION
    WILLIAMS, RL
    UPTON, RA
    BOSTROM, A
    JOURNAL OF ASTHMA, 1983, 20 (01) : 27 - 30
  • [35] Immediate-release versus controlled-release formulations: Pharmacokinetics of newer antidepressants in relation to nausea
    DeVane, CL
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 : 14 - 19
  • [36] Pharmacokinetics of extended-release metformin versus immediate-release metformin in healthy subjects.
    Niecestro, RM
    Lukacsko, P
    Lamson, MJ
    Walters, E
    Freidhoff, LT
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1063 - 1063
  • [37] Acetaminophen controlled-release sprinkles versus acetaminophen immediate-release elixir in febrile children
    Wilson, JT
    Helms, R
    Pickering, BD
    Donahue, L
    Brown, RD
    JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (04): : 360 - 369
  • [38] Pharmacokinetics and Pharmacodynamics of Immediate-Release Versus Extended-Release Guanfacine in Adult Daily Smokers
    Verplaetse, Terril L.
    Roberts, Walter
    Moore, Kelly E.
    Peltier, MacKenzie R.
    Oberleitner, Lindsay M.
    McKee, Sherry A.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2019, 39 (02) : 124 - 128
  • [39] Comparison of single-dose and multiple-dose pharmacokinetics between two formulations of hydrocodone bitartrate/acetaminophen: immediate-release versus biphasic immediate-release/extended release
    Devarakonda, Krishna
    Kostenbader, Kenneth
    Giuliani, Michael J.
    Young, Jim L.
    JOURNAL OF PAIN RESEARCH, 2015, 8 : 607 - 618
  • [40] Biowaivers for oral immediate-release products
    Faassen, F
    Vromans, H
    CLINICAL PHARMACOKINETICS, 2004, 43 (15) : 1117 - 1126
12345